Richardpruen (talk | contribs) (→Pregnancy: removed text from wrong section) |
|||
| Line 41: | Line 41: | ||
==Pain== | ==Pain== | ||
==Parkinson Disease== | ==Parkinson Disease== | ||
===2020 [https://academic.oup.com/ajcn/advance-article-abstract/doi/10.1093/ajcn/nqaa186/5876214?redirectedFrom=fulltext Dietary nicotine intake and risk of Parkinson disease: a prospective study]=== | |||
*At 26 year follow-up, women with greater dietary nicotine intake had a lower risk of [[Abbreviations|Parkinson Disease (PD)]] than those with lower intake. Dietary nicotine intake was calculated based on consumption of peppers, tomatoes, processed tomatoes, potatoes, and tea. | |||
*[https://sci-hub.st/10.1093/ajcn/nqaa186 PDF Version] | |||
*Citation: Chaoran Ma, Samantha Molsberry, Yanping Li, Michael Schwarzschild, Alberto Ascherio, Xiang Gao, Dietary nicotine intake and risk of Parkinson disease: a prospective study, The American Journal of Clinical Nutrition, Volume 112, Issue 4, October 2020, Pages 1080–1087, doi: 10.1093/ajcn/nqaa186 | |||
*Acknowledgements: Supported by National Institute of Neurological Disorders and Stroke at the NIH grant 1R03NS093245-01A1 (to XG). The Nurses’ Health Study | |||
is supported by the NIH through grant UM1 CA186107. The Health Professionals Follow-up Study cohort is supported by the NIH through grant U01 CA167552. | |||
*Keywords: dietary nicotine, Parkinson disease, neurodegenerative disease | |||
===2007 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2046219/ Nicotinic receptors as CNS targets for Parkinson’s disease]=== | |||
*Human and animal references | |||
*Analyzes results showing that chronic nicotine treatment improved striatal integrity and function. | |||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2046219/pdf/nihms32016.pdf PDF Version] | |||
*Citation: Quik M, Bordia T, O'Leary K. Nicotinic receptors as CNS targets for Parkinson's disease. Biochem Pharmacol. 2007 Oct 15;74(8):1224-34. doi: 10.1016/j.bcp.2007.06.015. Epub 2007 Jun 17. PMID: 17631864; PMCID: PMC2046219. | |||
*Acknowledgements: This work was supported by NIH grants NS42091 and NS47162. | |||
===1996 [https://pubmed.ncbi.nlm.nih.gov/9006184/ Does nicotine have beneficial effects in the treatment of certain diseases?]=== | |||
*Nicotine may have therapeutic uses in the treatment of [[Abbreviations|Parkinson's Disease]]. | |||
*Drug companies have often refused to fund legitimate and valid research into the potential therapeutic use of nicotine owing to its association with smoking and its image of an abusable drug. Many in the health profession fail to acknowledge the evidence which suggests that nicotine may have potential therapeutic value. | |||
*[https://sci-hub.st/10.12968/bjon.1996.5.19.1195 PDF Version] | |||
*Citation: Birtwistle J, Hall K. Does nicotine have beneficial effects in the treatment of certain diseases? Br J Nurs. 1996 Oct 24-Nov 13;5(19):1195-202. doi: 10.12968/bjon.1996.5.19.1195. PMID: 9006184. | |||
===1991 [https://pubmed.ncbi.nlm.nih.gov/1859921/ Beneficial effects of nicotine]=== | |||
*When chronically taken, nicotine may result in: protection against Parkinson's Disease (other diseases mentioned in study) | |||
*[https://sci-hub.st/10.1111/j.1360-0443.1991.tb01810.x PDF Version] | |||
*Citation: Jarvik ME. Beneficial effects of nicotine. Br J Addict. 1991 May;86(5):571-5. doi: 10.1111/j.1360-0443.1991.tb01810.x. PMID: 1859921. | |||
*Acknowledgement: Supported by U. C. Tobacco-related Disease program, grant # RT87 and a grant from the John D. and Catherine T. MacArthur Foundation. | |||
==Psoriasis== | ==Psoriasis== | ||
edits